Details for New Drug Application (NDA): 208122
✉ Email this page to a colleague
The generic ingredient in SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 208122
Tradename: | SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER |
Applicant: | Fresenius Kabi Usa |
Ingredient: | sodium chloride |
Patents: | 0 |
Pharmacology for NDA: 208122
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |
Suppliers and Packaging for NDA: 208122
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | sodium chloride | INJECTABLE;INJECTION | 208122 | ANDA | Becton Dickinson and Company | 17271-700 | 17271-700-02 | 60 BAG in 1 CASE (17271-700-02) / 50 mL in 1 BAG |
SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | sodium chloride | INJECTABLE;INJECTION | 208122 | ANDA | Becton Dickinson and Company | 17271-700 | 17271-700-03 | 50 BAG in 1 CASE (17271-700-03) / 100 mL in 1 BAG |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 450MG/100ML | ||||
Approval Date: | Jul 23, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription